Urology Devices Market by Product ((Dialysis, Endoscopes, Lasers, Lithotripsy, Robotic System), (Guidewires, Catheters, Stents)), Application (Kidney Diseases, Urological Cancer, BPH), End User (Hospital, Dialysis Center, Homecare) & Region - Global Forecast to 2026
Updated on : May 04, 2023
The global urology devices market in terms of revenue was estimated to be worth $38.0 billion in 2021 and is poised to reach $46.4 billion by 2026, growing at a CAGR of 4.1% from 2021 to 2026. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Investments by hospitals for procuring advanced instruments, expanding units, and establishing new centers are expected to boost the market for urology devices. Moreover, increased demand for MIS robotic systems is expected to increase in the coming years, which is expected to propel the market growth.
To know about the assumptions considered for the study, Request for Free Sample Report
Urology Devices Market Dynamics
Driver: Growing number of hospitals and investments in endoscopy and laparoscopy facilities
With the rising patient preference for minimally invasive procedures, the number of hospitals providing urology procedures such as endoscopy and laparoscopy is increasing. Hospitals that already have endoscopy equipment are also investing in new technologies and expanding their endoscopy units. This scenario is observed in all regions across the globe. In January 2021, Fairfield General Hospital opened a new Greater Manchester Endoscopy Modular Unit in Bury. The unit has been specially commissioned by Greater Manchester Health and Social Care Partnership to support the delivery of endoscopy services following the pandemic disruption. Such investments by hospitals for procuring advanced instruments, expanding units, and establishing new centers are expected to boost the market for urology devices such as endoscopes and endovision systems for effective treatment and management of urological conditions.
Opportunity: Emerging markets offer lucrative opportunities
Expansion of the private healthcare sector to accommodate the needs of the growing middle-class population is one of the major factor propelling the market growth. The middle-class population in the Asia Pacific is expected to increase to 66% by 2030 from 28% in 2009 (Source: OECD). According to the same source, the purchasing power of the growing middle-class population is expected to increase to 59% by 2020 from 23% in 2009. With rising disposable incomes and increasing medical needs of the middle-class population, urology device manufacturers are compelled to devise new strategies to meet this demand. The emerging markets are underpenetrated by major players, which indicates huge untapped market potential.
Restraint: High cost of urology devices
The high cost of urology endoscopes and endovision systems is a major factor restraining market growth, particularly in price-sensitive regions such as the Asia Pacific and the RoW. Healthcare providers, especially in developing countries such as Brazil and Mexico, have low financial resources to invest in such costly sophisticated technologies. Moreover, the staff should be trained for the efficient handling and maintenance of urology devices. Maintaining urology devices such as endoscopic devices is of vital importance as improperly reprocessed endoscopes can lead to cross-contamination and can potentially expose patients to infections. This can further add to the already high costs. This is one of the major factors responsible for physicians and patients opting for lower-priced alternative methods.
Instruments segment to dominate the urology devices market
Technological advancements coupled with the launch of new and advanced urology instruments and the increasing incidence of kidney diseases are the major factors driving the growth of the instruments segment. However, the repetitive use of instruments for surgeries can cause infections. To prevent infections from occurring, the instruments are sterilized and disinfected. The reuse of such instruments after sterilization and disinfection can be a major challenge to the growth of the market as it limits the demand for new products.
Kidney diseases segment is expected to have largest share of the urology devices market during the forecast period
Kidney disease is one of the leading causes of death across the globe. Early diagnosis and treatment help to reduce further damage to the kidney, thereby helping in disease management. If left untreated, it may lead to kidney failure or end-stage renal disease (ESRD), a severe life-threatening condition. Therefore, the growing incidence of kidney diseases coupled with the health complications associated with them is driving the demand for urological interventions to manage them, which, in turn, is propelling the market for urology devices.
Hospitals, ASCs, and clinics segment is expected to have largest share of the urology devices market during the forecast period
Hospitals, ASCs, and clinics provide urology diagnostic services and treatment and are equipped with extensive infrastructure to carry out invasive and noninvasive procedures that may not be available with pathology laboratories attached to medical care centers. They offer various advantages like better and specialized testing capabilities, efficient billing and collection systems, technologically advanced urology devices, and lower test costs. Additionally, the growth in the number of ASCs, coupled with the growing number of surgical procedures performed in ASCs, is expected to drive the demand for urology devices in this end-user segment.
Asia Pacific is expected to be the fastest growing region of the urology devices market during the forecast period.
The Asia Pacific is the third-largest market for urology devices globally. Currently, the market in the Asia Pacific is relatively smaller than developed markets across North America and Europe. However, the Asia Pacific market is expected to grow at the highest CAGR during the forecast period. The Asia Pacific, which is becoming a medical tourism hub, is considered one of the fastest-growing markets for medical procedures and devices. Low infrastructure and treatment costs and the availability of highly educated physicians have driven medical tourists to APAC countries. This is a major factor aiding the growth of the market in the Asia Pacific.
To know about the assumptions considered for the study, download the pdf brochure
Some key players in the urology devices market are:
- Fresenius Medical Care AG & Co. KGaA (Germany)
- Baxter International Inc. (US)
- Olympus Corporation (Japan)
- Boston Scientific Corporation (US)
- Becton, Dickinson and Company (US)
Urology Devices Market Report Scope
|
Report Metric |
Details |
|
Market Revenue in 2021 |
$38.8 billion |
|
Projected Revenue by 2026 |
$46.4 billion |
|
Revenue Rate |
Poised to grow at a CAGR of 4.1% |
|
Market Driver |
Growing number of hospitals and investments in endoscopy and laparoscopy facilities |
|
Market Opportunity |
Emerging markets offer lucrative opportunities |
This study categorizes the global urology devices market to forecast revenue and analyze trends in each of the following submarkets:
By Product
- Instruments
-
Dialysis Devices
- Hemodialysis Devices
- Peritoneal Dialysis Devices
-
Endoscopes
- Laparoscopes
- Ureteroscopes
- Nephroscopes
- Resectoscopes
- Cystoscopes
- Laser & Lithotripsy Devices
- Endovision & Imaging Devices
- Robotic Systems
- Insufflators
- Endoscopy Fluid Management Systems
- Urodynamic Systems
- Consumables & Accessories
- Dialysis Consumables
- Catheters
- Guidewires
- Retrieval Devices & Extractors
- Surgical Dissectors, Forceps, & Needle Holders
- Dilator Sets & Urethral Access Sheaths
- Stents
- Biopsy Devices
- Tubes & Distal Attachments
- Drainage Bags
- Other Consumables & Accessories
By Application
- Kidney Diseases
- Urological Cancer & BPH
- Pelvic Organ Prolapse
- Other Applications
By End User
- Hospitals, ASCs, & Clinics
- Dialysis Centers
- Home Care Settings
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
-
Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Recent Developments
- In November 2020, Baxter International Inc. (US) received 510(k) approval from the FDA for its Homechoice Claria automated peritoneal dialysis system with the Sharesource connectivity platform.
- In May 2019, Fresenius Medical Care AG & Co. KGaA (Germany) announced the establishment of a new distribution center in Knoxville, Tennessee. This expansion will support the delivery of products needed for in-center hemodialysis treatment.
- In February 2019, Fresenius Medical Care AG & Co. KGaA (Germany) acquired NxStage Medical, Inc. (US) to widen its product portfolio in the areas of renal and critical care.
Frequently Asked Questions (FAQ):
What is the projected market revenue value of the global urology devices market?
The global urology devices market boasts a total revenue value of $46.4 billion by 2026.
What is the estimated growth rate (CAGR) of the global urology devices market?
The global urology devices market has an estimated compound annual growth rate (CAGR) of 4.1% and a revenue size in the region of $38.0 billion in 2021.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 23)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.2.2 MARKETS COVERED
FIGURE 1 UROLOGY DEVICES MARKET SEGMENTATION
1.2.3 YEARS CONSIDERED FOR THE STUDY
1.3 CURRENCY
1.4 LIMITATIONS
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 28)
2.1 RESEARCH DATA
2.2 RESEARCH APPROACH
FIGURE 2 UROLOGY DEVICES MARKET: RESEARCH DESIGN
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
FIGURE 4 MARKET: BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
FIGURE 5 MARKET: TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 6 DATA TRIANGULATION METHODOLOGY
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY (Page No. - 36)
FIGURE 7 UROLOGY DEVICES MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 8 MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
FIGURE 9 MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 10 MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)
4 PREMIUM INSIGHTS (Page No. - 39)
4.1 UROLOGY DEVICES MARKET OVERVIEW
FIGURE 11 RISING PREVALENCE OF UROLOGICAL CONDITIONS TO DRIVE MARKET GROWTH
4.2 UROLOGY INSTRUMENTS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 12 DIALYSIS DEVICES SEGMENT WILL CONTINUE TO DOMINATE THE MARKET IN 2026
4.3 UROLOGY ENDOSCOPES MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 13 LAPAROSCOPES SEGMENT DOMINATES THE MARKET IN 2021
4.4 MARKET SHARE, BY END USER, 2021 VS. 2026
FIGURE 14 HOSPITALS, ASCS, & CLINICS ARE THE LARGEST END USERS OF UROLOGY DEVICES
4.5 MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 15 ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH RATE IN THE MARKET DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 43)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 UROLOGY DEVICES MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES
5.2.1 DRIVERS
5.2.1.1 Rising incidence and prevalence of urological conditions
TABLE 1 GLOBAL PREVALENCE OF URINARY INCONTINENCE
TABLE 2 GLOBAL UROLOGIC CANCER INCIDENCE
TABLE 3 GLOBAL INCIDENCE & PREVALENCE OF PROSTATE CANCER
5.2.1.2 Growing preference for minimally invasive procedures
5.2.1.3 Growing number of hospitals and investments in endoscopy and laparoscopy facilities
5.2.2 RESTRAINTS
5.2.2.1 High degree of consolidation
5.2.2.2 High cost of urology devices
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets offer lucrative opportunities
5.3 IMPACT OF COVID-19 ON THE MARKET
5.4 PRICING ANALYSIS
TABLE 4 PRICES OF UROLOGY DEVICES (2020)
5.5 PATENT ANALYSIS
5.6 VALUE CHAIN ANALYSIS
FIGURE 17 MAJOR VALUE IS ADDED DURING THE MANUFACTURING & ASSEMBLY PHASE
5.7 SUPPLY CHAIN ANALYSIS
FIGURE 18 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES
5.8 ECOSYSTEM ANALYSIS OF THE MARKET
FIGURE 19 ECOSYSTEM ANALYSIS OF THE MARKET
5.9 PORTER’S FIVE FORCES ANALYSIS
FIGURE 20 HIGH CAPITAL INVESTMENTS TO RESTRICT THE ENTRY OF NEW PLAYERS
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF BUYERS
5.9.4 BARGAINING POWER OF SUPPLIERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 PESTLE ANALYSIS
5.11 REGULATORY LANDSCAPE
5.11.1 NORTH AMERICA
5.11.1.1 US
5.11.1.2 Canada
5.11.2 EUROPE
5.11.3 ASIA PACIFIC
5.11.3.1 China
5.11.3.2 Japan
5.11.3.3 India
5.11.3.4 South Korea
5.11.4 LATIN AMERICA
5.11.4.1 Brazil
5.11.4.2 Mexico
5.11.5 MIDDLE EAST
5.11.6 AFRICA
5.12 TRADE ANALYSIS
5.12.1 TRADE ANALYSIS FOR DIALYSIS INSTRUMENTS
5.12.1.1 Import data for dialysis instruments, by country, 2016—2020 (USD Million)
5.12.2 TRADE ANALYSIS FOR ENDOSCOPES
5.12.2.1 Import data for endoscopes, by country, 2016—2020 (USD Million)
6 UROLOGY DEVICES MARKET, BY PRODUCT (Page No. - 59)
6.1 INTRODUCTION
TABLE 5 MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
6.2 INSTRUMENTS
TABLE 6 UROLOGY INSTRUMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 7 UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.2.1 DIALYSIS DEVICES
TABLE 8 DIALYSIS DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 9 DIALYSIS DEVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.2.1.1 Hemodialysis devices
6.2.1.1.1 HHD has gained significance due to improved clinical outcomes for patients
TABLE 10 HEMODIALYSIS DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.1.2 Peritoneal dialysis devices
6.2.1.2.1 Technological advancements in PD devices and increasing product approvals to propel market growth
TABLE 11 PERITONEAL DIALYSIS DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.2 ENDOSCOPES
TABLE 12 ENDOSCOPES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 13 ENDOSCOPES MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.2.2.1 Laparoscopes
6.2.2.1.1 Growing number of laparoscopy procedures to support the market growth
TABLE 14 LAPAROSCOPES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.2.2 Ureteroscopes
6.2.2.2.1 Continuous technological advancements to support the growth of this market
TABLE 15 URETEROSCOPES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.2.3 Nephroscopes
6.2.2.3.1 High cost of maintenance to restrain the market growth
TABLE 16 NEPHROSCOPES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.2.4 Resectoscopes
6.2.2.4.1 High prevalence of prostate, kidney, and bladder cancers to drive the demand for resectoscopes
TABLE 17 RESECTOSCOPES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.2.5 Cystoscopes
6.2.2.5.1 Increasing prevalence and incidence of urological cancers to drive the uptake to cystoscopes for early diagnosis and treatment
TABLE 18 CYSTOSCOPES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.3 LASER & LITHOTRIPSY DEVICES
6.2.3.1 Increasing prevalence of kidney diseases to support market growth
TABLE 19 LASER & LITHOTRIPSY DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.4 ENDOVISION & IMAGING SYSTEMS
6.2.4.1 Need for high-resolution images for better observation of body cavities and organs to propel the market in the coming years
TABLE 20 ENDOVISION & IMAGING SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.5 ROBOTIC SYSTEMS
6.2.5.1 Growing industry-academia collaborations to support market growth
TABLE 21 ROBOTIC SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.6 INSUFFLATORS
6.2.6.1 Increasing volume of laparoscopic procedures to boost the demand for insufflators
TABLE 22 INSUFFLATORS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.7 ENDOSCOPY FLUID MANAGEMENT SYSTEMS
6.2.7.1 Growing incidence of chronic diseases to drive the market growth
TABLE 23 ENDOSCOPY FLUID MANAGEMENT SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.2.8 URODYNAMIC SYSTEMS
6.2.8.1 Growing patient pool to support the growth of this product segment
TABLE 24 URODYNAMIC SYSTEMS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3 CONSUMABLES & ACCESSORIES
TABLE 25 UROLOGY CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 26 UROLOGY CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2019–2026 (USD MILLION)
6.3.1 DIALYSIS CONSUMABLES
6.3.1.1 Growing number of dialysis procedures to support market growth
TABLE 27 DIALYSIS CONSUMABLES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.2 CATHETERS
6.3.2.1 High prevalence of urinary incontinence will drive the market for catheters
TABLE 28 CATHETERS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.3 GUIDEWIRES
6.3.3.1 Development of next-generation hybrid guidewires has created significant growth opportunities
TABLE 29 GUIDEWIRES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.4 RETRIEVAL DEVICES & EXTRACTORS
6.3.4.1 Technological advancements to support market growth
TABLE 30 MARKET FOR RETRIEVAL DEVICES & EXTRACTORS, BY REGION, 2019–2026 (USD MILLION)
6.3.5 SURGICAL DISSECTORS, FORCEPS, & NEEDLE HOLDERS
6.3.5.1 Growing number of urology procedures to support market growth
TABLE 31 SURGICAL DISSECTORS, FORCEPS, & NEEDLE HOLDERS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.6 DILATOR SETS & URETHRAL ACCESS SHEATHS
6.3.6.1 Growing demand for effective endoscopic management of ureteral and renal calculi to support market growth
TABLE 32 DILATOR SETS & URETHRAL ACCESS SHEATHS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.7 STENTS
6.3.7.1 Growing prevalence of urological and kidney-related disorders to propel market growth
TABLE 33 STENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.8 BIOPSY DEVICES
6.3.8.1 High incidence of prostate cancer to drive the uptake of biopsy devices
TABLE 34 BIOPSY DEVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.9 TUBES & DISTAL ATTACHMENTS
6.3.9.1 Growing demand for endoscopy is expected to propel the growth of this segment
TABLE 35 TUBES & DISTAL ATTACHMENTS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.10 DRAINAGE BAGS
6.3.10.1 Risk of urinary tract infections and skin irritation to restrain the market growth
TABLE 36 DRAINAGE BAGS MARKET, BY REGION, 2019–2026 (USD MILLION)
6.3.11 OTHER CONSUMABLES & ACCESSORIES
TABLE 37 OTHER CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2019–2026 (USD MILLION)
7 UROLOGY DEVICES MARKET, BY APPLICATION (Page No. - 89)
7.1 INTRODUCTION
TABLE 38 MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
7.2 KIDNEY DISEASES
7.2.1 GROWING PREVALENCE OF DIABETES AND HYPERTENSION TO SUPPORT MARKET GROWTH
TABLE 39 MARKET FOR KIDNEY DISEASES, BY REGION, 2019–2026 (USD MILLION)
7.3 UROLOGICAL CANCER & BPH
7.3.1 RISING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO DRIVE THE MARKET GROWTH
TABLE 40 MARKET FOR UROLOGICAL CANCER & BPH, BY REGION, 2019–2026 (USD MILLION)
7.4 PELVIC ORGAN PROLAPSE
7.4.1 HIGH COSTS INVOLVED IN SURGERIES & HIGH REOCCURRENCE RATES TO RESTRAIN THE MARKET GROWTH
TABLE 41 MARKET FOR PELVIC ORGAN PROLAPSE, BY REGION, 2019–2026 (USD MILLION)
7.5 OTHER APPLICATIONS
TABLE 42 MARKET FOR OTHER APPLICATIONS, BY REGION, 2019–2026 (USD MILLION)
8 UROLOGY DEVICES MARKET, BY END USER (Page No. - 95)
8.1 INTRODUCTION
TABLE 43 MARKET, BY END USER, 2019–2026 (USD MILLION)
8.2 HOSPITALS, ASCS, & CLINICS
8.2.1 HOSPITALS, ASCS, & CLINICS ARE THE LARGEST END USERS OF UROLOGY DEVICES
TABLE 44 MARKET FOR HOSPITALS, ASCS, & CLINICS, BY REGION, 2019–2026 (USD MILLION)
8.3 DIALYSIS CENTERS
8.3.1 CHANGING REIMBURSEMENT POLICIES IN DEVELOPED COUNTRIES TO RESTRAIN THE MARKET GROWTH
TABLE 45 NUMBER OF DIALYSIS CENTERS IN THE US, BY COMPANY, 2019
TABLE 46 NUMBER OF DIALYSIS CENTERS IN CHINA, 2018
TABLE 47 MARKET FOR DIALYSIS CENTERS, BY REGION, 2019–2026 (USD MILLION)
8.4 HOME CARE SETTINGS
8.4.1 IMPROVED PATIENT OUTCOMES AND SHORTER HOSPITAL STAYS TO SUPPORT MARKET GROWTH
TABLE 48 MARKET FOR HOME CARE SETTINGS, BY REGION, 2019–2026 (USD MILLION)
9 UROLOGY DEVICES MARKET, BY REGION (Page No. - 101)
9.1 INTRODUCTION
TABLE 49 MARKET, BY REGION, 2019–2026 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 21 NORTH AMERICA: MARKET SNAPSHOT
TABLE 50 NORTH AMERICA: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 51 NORTH AMERICA: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 52 NORTH AMERICA: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 53 NORTH AMERICA: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2.1 US
9.2.1.1 The US dominates the North American urology devices market
TABLE 54 US: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 55 US: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 56 US: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 57 US: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Rising prevalence of target diseases to drive market growth in Canada
TABLE 58 CANADA: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 59 CANADA: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 60 CANADA: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 61 CANADA: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3 EUROPE
TABLE 62 EUROPE: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 63 EUROPE: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 64 EUROPE: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 65 EUROPE: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Germany to dominate the European urology devices market during the forecast period
TABLE 66 GERMANY: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 67 GERMANY: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 68 GERMANY: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 69 GERMANY: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.2 UK
9.3.2.1 Rising incidence of kidney conditions to drive market growth in the UK
TABLE 70 UK: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 71 UK: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 72 UK: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 73 UK: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Favorable government initiatives are supporting the market growth in France
TABLE 74 FRANCE: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 75 FRANCE: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 76 FRANCE: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 77 FRANCE: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Favorable medical and healthcare reimbursements are driving the market growth in Italy
TABLE 78 ITALY: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 79 ITALY: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 80 ITALY: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 81 ITALY: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Rising prevalence of CKD in Spain to drive market growth
TABLE 82 SPAIN: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 83 SPAIN: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 84 SPAIN: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 85 SPAIN: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 86 ROE: NUMBER OF CANCER CASES, BY COUNTRY, 2018
TABLE 87 ROE: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 88 ROE: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 89 ROE: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 90 ROE: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 22 ASIA PACIFIC: UROLOGY DEVICES MARKET SNAPSHOT
TABLE 91 APAC: MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 92 APAC: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 93 APAC: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 94 APAC: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.1 CHINA
9.4.1.1 China accounts for the largest share of the APAC market
TABLE 95 CHINA: UROLOGY DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 96 CHINA: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 97 CHINA: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 98 CHINA: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Favorable regulatory framework in Japan to support the market growth
TABLE 99 JAPAN: UROLOGY DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 100 JAPAN: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 101 JAPAN: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 102 JAPAN: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Healthcare infrastructure improvements and implementation of favorable government initiatives to support market growth in India
TABLE 103 INDIA: UROLOGY DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 104 INDIA: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 105 INDIA: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 106 INDIA: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.4.4 REST OF ASIA PACIFIC
TABLE 107 ROAPAC: UROLOGY DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 108 ROAPAC: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 109 ROAPAC: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 110 ROAPAC: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.5 LATIN AMERICA
9.5.1 HIGH PREVALENCE OF CHRONIC CONDITIONS TO DRIVE MARKET GROWTH
TABLE 111 LATIN AMERICA: MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 112 LATIN AMERICA: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 113 LATIN AMERICA: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 114 LATIN AMERICA: MARKET, BY END USER, 2019–2026 (USD MILLION)
9.6 MIDDLE EAST & AFRICA
9.6.1 INCREASING HEALTHCARE EXPENDITURE TO DRIVE THE MARKET GROWTH
TABLE 115 MIDDLE EAST & AFRICA: UROLOGY DEVICES MARKET, BY PRODUCT, 2019–2026 (USD MILLION)
TABLE 116 MIDDLE EAST & AFRICA: UROLOGY INSTRUMENTS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 117 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 118 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2019–2026 (USD MILLION)
10 COMPETITIVE LANDSCAPE (Page No. - 138)
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES
10.3 MARKET SHARE ANALYSIS
FIGURE 23 UROLOGY DEVICES MARKET SHARE, BY KEY PLAYER (2019)
10.4 COMPANY EVALUATION QUADRANT
10.4.1 LIST OF EVALUATED VENDORS
10.4.2 STARS
10.4.3 EMERGING LEADERS
10.4.4 PERVASIVE PLAYERS
10.4.5 PARTICIPANTS
FIGURE 24 UROLOGY DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
10.5 COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS (2019)
10.5.1 PROGRESSIVE COMPANIES
10.5.2 STARTING BLOCKS
10.5.3 RESPONSIVE COMPANIES
10.5.4 DYNAMIC COMPANIES
FIGURE 25 UROLOGY DEVICES MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS/SMES, 2019
10.6 COMPETITIVE SCENARIO
10.6.1 MARKET EVALUATION FRAMEWORK, 2018-2020
10.6.2 PRODUCT LAUNCHES & APPROVALS
TABLE 119 KEY PRODUCT LAUNCHES & APPROVALS
10.6.3 EXPANSIONS
TABLE 120 KEY EXPANSIONS
10.6.4 ACQUISITIONS
TABLE 121 KEY ACQUISITIONS
10.6.5 PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES
TABLE 122 KEY PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES
11 COMPANY PROFILES (Page No. - 148)
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1.1 FRESENIUS MEDICAL CARE AG & CO. KGAA
FIGURE 26 FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY SNAPSHOT (2019)
11.1.2 BAXTER INTERNATIONAL, INC.
FIGURE 27 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT (2019)
11.1.3 BOSTON SCIENTIFIC CORPORATION
FIGURE 28 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2019)
11.1.4 BECTON, DICKINSON AND COMPANY
FIGURE 29 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020)
11.1.5 OLYMPUS CORPORATION
FIGURE 30 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2020)
11.1.6 B. BRAUN MELSUNGEN AG
FIGURE 31 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2019)
11.1.7 STRYKER CORPORATION
FIGURE 32 STRYKER CORPORATION: COMPANY SNAPSHOT (2019)
11.1.8 INTUITIVE SURGICAL
FIGURE 33 INTUITIVE SURGICAL: COMPANY SNAPSHOT (2019)
11.1.9 MEDTRONIC PLC
FIGURE 34 MEDTRONIC PLC: COMPANY SNAPSHOT (2020)
11.1.10 CARDINAL HEALTH
FIGURE 35 CARDINAL HEALTH: COMPANY SNAPSHOT (2020)
11.2 OTHER PLAYERS
11.2.1 TELEFLEX INCORPORATED
FIGURE 36 TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2019)
11.2.2 KARL STORZ
11.2.3 COOK MEDICAL
11.2.4 RICHARD WOLF GMBH
11.2.5 COMPACTCATH
11.2.6 DORNIER MEDTECH
11.2.7 NIKKISO CO., LTD.
11.2.8 DIALIFE SA
11.2.9 MAXER ENDOSCOPY GMBH
11.2.10 WELL LEAD MEDICAL CO., LTD.
11.2.11 ROCAMED
11.2.12 ENDOMED SYSTEMS GMBH
11.2.13 AMSINO INTERNATIONAL, INC.
11.2.14 MEDISPEC
11.2.15 MEDICAL TECHNOLOGIES OF GEORGIA
11.2.16 VIMEX SP. Z O. O.
11.2.17 BALTON SP. Z O.O.
11.2.18 HUNTER UROLOGY
11.2.19 RIBBEL INTERNATIONAL LIMITED
11.2.20 J & M URINARY CATHETERS, LLC
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.
12 APPENDIX (Page No. - 191)
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
This study involved four major activities in estimating the current size of the urology devices market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the urology devices market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research
- The revenues generated by leading players operating in the urology devices market have been determined through primary and secondary research
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
To know about the assumptions considered for the study, Request for Free Sample Report
Data Triangulation
After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Report Objectives
- To define, describe, segment, and forecast the global urology devices market by product, application, end user, and region
- To provide detailed information regarding the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
- To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies2
- To track and analyze company developments such as product launches, partnerships, expansions, and acquisitions in the urology devices market
- To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:
Country Information
Urology devices market size and growth rate estimates for countries in the Rest of Europe, the Rest of Asia Pacific, Latin America, and Middle East & Africa
Company profiles
Additional five company profiles of players operating in the urology devices market
Generating Response ...
Growth opportunities and latent adjacency in Urology Devices Market